Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction

Cardiology Journal

Volumn 15, Issue 1, 2008, Pages 57-62

  Olszowska, Maria ^a,b   Tracz, Wiesława ^a   Kostkiewicz, Magdalena ^a   Podolec, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE   (Poland)

Author keywords

Contrast echocardiography; Coronary angioplasty no reflow phenomenon; Myocardial perfusion

Indexed keywords

ABCIXIMAB; ALTEPLASE; CREATINE KINASE MB; TROPONIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; DRUG DOSE REDUCTION; ELECTRICAL POTENTIAL PARAMETERS; FACTORIAL ANALYSIS; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROTEIN BLOOD LEVEL; SCORING SYSTEM; ST SEGMENT; THORAX PAIN;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 41149091142     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zijlstra F, Hoorntje JC, de Boer MJ et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med, 1999; 341: 1413-1419.
2. Zeymer U, Schröder R, Machnig T, Neuhaus KL. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Am Heart J, 2003; 146: 686-691.
3. Morishima I, Sone T, Okumura K et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol, 2000; 38: 1202-1209.
4. Porter TR, Cwajg J. Myocardial contrast echocardiography: A new gold standard for perfusion imaging? Echocardiography, 2001; 18: 79-87.
5. Lafitte S, Higashiyama A, Masugata H et al. Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: Experimental validation. J Am Coll Cardiol, 2002; 39: 1546-1554.
6. 99mTc sestamibi SPECT for detecting of resting myocardial perfusion abnormalities in patients with previous myocardial infarction. Heart, 2000; 83: 518-524.
7. Greaves K, Dixon SR, Fejka M et al. Myocardial contrast echocardiography is superior to other know modalities for assessing myocardial reperfusion after acute myocardial infarction. Heart, 2003; 89: 139-144.
8. Lepper W, Sieswerda GT, Vanoverschelde JI, et al. Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function. Am J Cardiol, 2001; 88: 1358-1363.
9. Schiller NB, Shah PM, Crawford M. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiogram. J Am Soc Echocardiogr, 1989; 2: 358-367.
10. de Lemos JA, Braunwald E. ST-segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol, 2001; 38: 1283-1294.
11. The TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med, 1993; 312: 932-936.
12. Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation, 1996; 93: 879-888.
13. Gibson CM, Cannon CP, Murphy SA et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation, 2000; 101: 125-130.
14. Ito H, Maruyama A, Iwakura K et al. Clinical implication of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation, 1996; 93: 223-228.
15. Swinburn J, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol, 2002; 38: 19-25.
16. Cura FA, L'Allier PL, Kapadia SR et al. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol, 2001; 88: 124-128.
17. Czitrom D, Karila-Cohen D, Brochest E et al. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery. Heart, 1999; 81: 12-16.
18. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol, 1989; 64: 155-160.
19. Stone GW, Cox D, Garcia E et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation, 2001; 104: 624-626.
20. Lim YJ, Masuyama T, Mishima M et al. Effect of prereperfusion residual flow on recovery from myocardial stunning: A myocardial contrast echocardiography study. J Am Soc Echocardiogr, 2000; 13: 18-25.
21. Yip HK, Chen MC, Chang HW et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow phenomenon. Chest, 2002; 122: 1322-1332.
22. Brodie BR, Stone GW, Morice MC et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Harction Trial). Am J Cardiol, 2001; 15: 1085-1090.
23. Corbalan R, Larrain G, Nazzal C et al. Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol, 2001; 88: 342-346.
24. Haager PK, Christott P, Heussen N, Lepper W, Hanrath P, Hoffmann R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol, 2003; 41: 532-538.
25. Iwakura K, Ito H, Kawano S et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol, 2001; 38: 472-477.
26. Kosuge M, Kimura K, Ishikawa T et al. Reliability of resolution of ST-segment elevation after coronary reperfusion in predicting myocardial salvage in anterior wall acute myocardial infarction. Am J Cardiol, 2002; 90: 227-232.
27. Takahashi T, Anzai T, Yoshikawa T et al. Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction. Int J Cardiol, 2000; 75: 253-260.
28. Kosuge M, Kimura K, Kojima S et al. Effects of preinfarction angina pectoris on infarct size and in-hospital mortality after coronary intervention for acute myocardial infarction. Am J Cardiol, 2003; 92: 840-843.
29. Iwakura K, Ito H, Ikushima M et al Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol, 2003; 41: 1-7.